Brind.
  1. TerrAscend is headquartered in Mississauga, and the company cultivates and sells cannabis in the US and Canada. The company also interacts with Terumo, which sells medical products in the US and Japan.

Terumo and Integer Stock Comparison Highlights Valuation Differences

1 report, 1 independent Updated Oct 11
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

A comparison of Terumo and Integer shows that Terumo has higher revenue and earnings than Integer. Terumo is trading at a lower price-to-earnings ratio, while analysts suggest Integer may be more favorable due to its higher probable upside.

From tickerreport.com

Why it matters

Some supportBrind's analysis of the reports

The comparison highlights differences in market risk and valuation between the two healthcare companies. Terumo's beta of 0.77 indicates its share price is 23% less volatile than the S&P 500, while Integer has a beta of 0.58.

From tickerreport.com

Who's involved

  • TerumoHealthcare company whose financial metrics are compared.
  • NomuraCorporation that provides financial research notes concerning Terumo.
  • MarketBeatPlatform that collects and publishes analyst ratings regarding Terumo.

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped